Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Fingolimod | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Fingolimod | hsa00051 | Fructose and mannose metabolism | 3.92E-03 | 3 | P15121, P19367, P08237 | AKR1B1, HK1, PFKM | More | | Fingolimod | hsa00052 | Galactose metabolism | 3.92E-03 | 3 | P08237, P15121, P19367 | PFKM, AKR1B1, HK1 | More | | Fingolimod | hsa00564 | Glycerophospholipid metabolism | 3.56E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Fingolimod | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Fingolimod | hsa00790 | Folate biosynthesis | 1.04E-02 | 3 | Q92820, P05186, P42330 | GGH, ALPL, AKR1C3 | More | | Fingolimod | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Fingolimod | hsa00983 | Drug metabolism - other enzymes | 2.61E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Fingolimod | hsa01100 | Metabolic pathways | 1.28E-02 | 16 | Q9Y234, P35790, Q16772, P30041, P19367, P48426, P22557, P20839, Q9Y6K0, P15121, P08237, O95861, Q86VZ5, P48651, Q969G6, P14927 | LIPT1, CHKA, GSTA3, PRDX6, HK1, PIP4K2A, ALAS2, IMPDH1, CEPT1, AKR1B1, PFKM, BPNT1, SGMS1, PTDSS1, RFK, UQCRB | More | | Fingolimod | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Fingolimod | hsa01240 | Biosynthesis of cofactors | 4.63E-02 | 3 | Q969G6, P22557, Q9Y234 | RFK, ALAS2, LIPT1 | More | | Fingolimod | hsa01522 | Endocrine resistance | 4.74E-02 | 3 | P22694, P10415, Q13323 | PRKACB, BCL2, BIK | More | | Fingolimod | hsa01523 | Antifolate resistance | 4.16E-02 | 3 | P41440, Q92820, P01375 | SLC19A1, GGH, TNF | More | | Fingolimod | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Fingolimod | hsa03010 | Ribosome | 5.85E-04 | 8 | P62753, P25398, P32969, P46776, P62899, P18077, P61927, P36578 | RPS6, RPS12, RPL9, RPL27A, RPL31, RPL35A, RPL37, RPL4 | More | | Fingolimod | hsa03013 | RNA transport | 1.44E-07 | 19 | O14980, P52298, O14893, P61326, Q15287, Q9H307, Q7Z3B4, P35658, P68104, P47813, Q14152, O15371, P11940, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, GEMIN2, MAGOH, RNPS1, PNN, NUP54, NUP214, EEF1A1, EIF1AX, EIF3A, EIF3D, PABPC1, EIF4A2, UPF3B, EIF4B, TACC3, FMR1, FXR1 | More | | Fingolimod | hsa03420 | Nucleotide excision repair | 4.17E-02 | 2 | P49005, P15927 | POLD2, RPA2 | More | | Fingolimod | hsa04060 | Cytokine-cytokine receptor interaction | 2.61E-02 | 10 | P27930, P08476, P25024, P25025, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, CXCR1, CXCR2, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Fingolimod | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.39E-04 | 8 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL2RB, TNF | More | | Fingolimod | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Fingolimod | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Fingolimod | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Fingolimod | hsa04080 | Neuroactive ligand-receptor interaction | 2.50E-05 | 10 | P08311, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P07550, P35318 | CTSG, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, ADRB2, ADM | More | | Fingolimod | hsa04120 | Ubiquitin mediated proteolysis | 1.74E-03 | 8 | Q14145, Q9UJX2, Q13042, Q93034, Q13191, P61088, Q15751, Q7Z6Z7 | KEAP1, CDC23, CDC16, CUL5, CBLB, UBE2N, HERC1, HUWE1 | More | | Fingolimod | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Fingolimod | hsa04140 | Autophagy - animal | 4.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | | Fingolimod | hsa04141 | Protein processing in endoplasmic reticulum | 8.43E-03 | 5 | P18848, Q12933, Q15436, Q99941, P07900 | ATF4, TRAF2, SEC23A, CREBL1, HSP90AA1 | More | | Fingolimod | hsa04151 | PI3K-Akt signaling pathway | 2.73E-03 | 7 | P62753, P27348, P07900, Q16363, P22105, Q99941, P18848 | RPS6, YWHAQ, HSP90AA1, LAMA4, TNXB, CREBL1, ATF4 | More | | Fingolimod | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Fingolimod | hsa04217 | Necroptosis | 1.71E-02 | 4 | Q12933, P07900, P05141, Q13557 | TRAF2, HSP90AA1, SLC25A5, CAMK2D | More | | Fingolimod | hsa04270 | Vascular smooth muscle contraction | 3.82E-02 | 5 | P24723, Q04759, Q14643, P22694, P35318 | PRKCH, PRKCQ, ITPR1, PRKACB, ADM | More | | Fingolimod | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Fingolimod | hsa04540 | Gap junction | 2.86E-02 | 3 | P22694, P68371, Q14643 | PRKACB, TUBB2C, ITPR1 | More | | Fingolimod | hsa04610 | Complement and coagulation cascades | 3.19E-02 | 1 | P0C0L4 | C4A | More | | Fingolimod | hsa04612 | Antigen processing and presentation | 8.50E-04 | 8 | P13765, P48382, P26715, P26717, Q07444, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRC3, KLRD1, CD8A, TNF | More | | Fingolimod | hsa04613 | Neutrophil extracellular trap formation | 6.26E-03 | 11 | P05164, P08246, Q9UM07, Q13547, Q16778, P20160, P08311, P49913, O75015, P21730, P21462 | MPO, ELA2, PADI4, HDAC1, HIST2H2BE, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1 | More | | Fingolimod | hsa04640 | Hematopoietic cell lineage | 5.96E-04 | 12 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Fingolimod | hsa04650 | Natural killer cell mediated cytotoxicity | 9.30E-08 | 13 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, Q07444, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KLRC1 | More | | Fingolimod | hsa04657 | IL-17 signaling pathway | 4.36E-02 | 2 | P07900, Q12933 | HSP90AA1, TRAF2 | More | | Fingolimod | hsa04658 | Th1 and Th2 cell differentiation | 1.26E-07 | 12 | Q04759, P07766, P20963, P09693, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Fingolimod | hsa04659 | Th17 cell differentiation | 1.10E-04 | 11 | Q04759, P19174, P06239, P14784, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Fingolimod | hsa04660 | T cell receptor signaling pathway | 1.67E-04 | 11 | P01375, Q04759, P42338, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239 | TNF, PRKCQ, PIK3CB, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Fingolimod | hsa04668 | TNF signaling pathway | 1.85E-02 | 3 | Q12933, Q99941, P18848 | TRAF2, CREBL1, ATF4 | More | | Fingolimod | hsa04723 | Retrograde endocannabinoid signaling | 3.54E-02 | 3 | P62873, Q08828, O15239 | GNB1, ADCY1, NDUFA1 | More | | Fingolimod | hsa04725 | Cholinergic synapse | 3.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | | Fingolimod | hsa04728 | Dopaminergic synapse | 4.10E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Fingolimod | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Fingolimod | hsa04911 | Insulin secretion | 5.41E-03 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Fingolimod | hsa04913 | Ovarian steroidogenesis | 2.72E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Fingolimod | hsa04918 | Thyroid hormone synthesis | 1.44E-02 | 3 | Q99941, P18848, P02768 | CREBL1, ATF4, ALB | More | | Fingolimod | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Fingolimod | hsa04924 | Renin secretion | 2.05E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Fingolimod | hsa04925 | Aldosterone synthesis and secretion | 1.44E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Fingolimod | hsa04927 | Cortisol synthesis and secretion | 3.17E-03 | 4 | Q14643, Q99941, P18848, P22694 | ITPR1, CREBL1, ATF4, PRKACB | More | | Fingolimod | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.02E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | | Fingolimod | hsa04934 | Cushing syndrome | 2.11E-04 | 7 | Q14643, Q99941, P18848, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ATF4, PRKACB, AXIN1, CAMK2D, WNT1 | More | | Fingolimod | hsa04970 | Salivary secretion | 2.11E-02 | 3 | P07550, P22694, Q14643 | ADRB2, PRKACB, ITPR1 | More | | Fingolimod | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Fingolimod | hsa05016 | Huntington disease | 7.64E-03 | 7 | O15239, P12074, P05496, P24928, P62487, P05141, P43686 | NDUFA1, COX6A1, ATP5G1, POLR2A, POLR2G, SLC25A5, PSMC4 | More | | Fingolimod | hsa05020 | Prion disease | 1.62E-02 | 7 | P46531, O15239, P05496, P12074, P05141, P43686, P67870 | NOTCH1, NDUFA1, ATP5G1, COX6A1, SLC25A5, PSMC4, CSNK2B | More | | Fingolimod | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.57E-02 | 7 | P67870, O15239, P12074, P05496, P05141, P20333, P43686 | CSNK2B, NDUFA1, COX6A1, ATP5G1, SLC25A5, TNFRSF1B, PSMC4 | More | | Fingolimod | hsa05030 | Cocaine addiction | 4.36E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Fingolimod | hsa05031 | Amphetamine addiction | 5.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Fingolimod | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Fingolimod | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Fingolimod | hsa05143 | African trypanosomiasis | 3.19E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Fingolimod | hsa05146 | Amoebiasis | 2.95E-07 | 11 | P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Fingolimod | hsa05150 | Staphylococcus aureus infection | 8.72E-04 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Fingolimod | hsa05161 | Hepatitis B | 2.86E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Fingolimod | hsa05168 | Herpes simplex virus 1 infection | 4.79E-02 | 8 | P25963, Q07955, Q01130, Q9Y2A4, P51522, P17038, P52738, O75820 | NFKBIA, SFRS1, SFRS2, ZNF443, ZNF83, ZNF43, ZNF140, ZNF189 | More | | Fingolimod | hsa05171 | Coronavirus disease - COVID-19 | 3.22E-04 | 15 | P23458, P62753, P25398, P39019, P42677, P62906, P36578, P32969, P30050, P46776, P62899, P18077, P61927, P61513, P05386 | JAK1, RPS6, RPS12, RPS19, RPS27, RPL10A, RPL4, RPL9, RPL12, RPL27A, RPL31, RPL35A, RPL37, RPL37A, RPLP1 | More | | Fingolimod | hsa05202 | Transcriptional misregulation in cancer | 2.67E-03 | 11 | P14780, P27930, Q15744, Q16548, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | | Fingolimod | hsa05203 | Viral carcinogenesis | 1.19E-02 | 4 | Q12933, Q99941, P18848, P27348 | TRAF2, CREBL1, ATF4, YWHAQ | More | | Fingolimod | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Fingolimod | hsa05310 | Asthma | 1.04E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Fingolimod | hsa05321 | Inflammatory bowel disease | 2.08E-04 | 5 | P01375, P13765, Q14765, Q9UL17, P23771 | TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Fingolimod | hsa05322 | Systemic lupus erythematosus | 2.78E-02 | 7 | O75015, P08246, P08311, P01375, P13765, Q16778, P12814 | FCGR3B, ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Fingolimod | hsa05332 | Graft-versus-host disease | 1.12E-03 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |